Skip to main content

Table 1 [3H]Paroxetine binding characteristics in platelet membranes of control subjects and patients with fibromyalgia

From: Alteration of serotonin transporter density and activity in fibromyalgia

Variable Controls (n = 38) Patients with FM (n = 40)
Bmax (fmol/mg protein) 1,260 ± 34 1,048 ± 30a
Kd (nM) 0.077 ± 0.012 0.086 ± 0.021
  1. Results are shown as means ± SEM. Bmax, maximal membrane binding capacity; FM, fibromyalgia; Kd, dissociation constant. ap < 0.0001.